nci legislative update...nci legislative update clinical trials and translational research advisory...

13
NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government and Congressional Relations

Upload: others

Post on 04-Jul-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

NCI Legislative Update Clinical Trials and Translational Research Advisory Committee

November 4, 2015

M.K. Holohan, J.D. Director

NCI Office of Government and Congressional Relations

Page 2: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

Discussion Topics

Recent Congressional Activity

Budget Deal

House GOP Leadership Changes

Appropriations – still pending

Key Issues

Presenter
Presentation Notes
Susan
Page 3: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

Where we were ... Appropriations FY 2016

Budget Caps Limit Possible Options

House LHHS Committee Approved FY 2016 bill on June 24, 2015

Provides NIH $31.2 billion, an increase of 1.1 billion above FY2015 Includes $200 million for Precision Medicine Initiative, $70 million to

NCI Targets specific research areas, providing increased funding for

Alzheimer’s disease research, Clinical Translational Sciences Awards, the BRIAN initiative, among others.

Provides NCI $5.081 billion

Senate LHHS Committee Approved FY 2016 bill on June 25, 2015

Provides NIH $32 billion, an increase of $2 billion above FY2015 Includes $200 million for Precision Medicine Initiative, $70 million to

NCI Targets specific research areas, providing increased funding for

Alzheimer’s disease research, BRAIN initiative, and the Combating Antibiotic Resistant Bacteria program, among others.

Provides NCI $5.204 billion

Presenter
Presentation Notes
MK Mention that it has been several years since both House and Senate have reported the LHHS bill out of Committee. This is he first time the House Appropriations Committee has passed an LHHS bill in six years. For the Senate Reported bill note that this is the largest increase for NIH since 2003 when the doubling ended House ---- Subcommittee Ranking Member DeLauro (D-CT) offered an amendment to increase funding for NIH by $3 billion by adding the text of her bill HR 531, the Accelerating Biomedical Research Act. The amendment was rejected by a party line vo20-30 vote. Senate – LHHS Ranking Member Patty Murray (D-WA) offered an amendment to increase the overall LHHS bill funding to the original amount detailed for FY2016 in the Budget Control Act before sequestration. This amendment failed on party line vote of 14-16. .
Page 4: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government
Page 5: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

• Short Term CR – Dec 11

• Speaker of the House Boehner resigns Sept 25 • Majority Leader Kevin McCarthy – short-lived heir

apparent – drops out of race October 8th

• Leadership vacuum

Page 6: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

• The House passed the Bipartisan Budget Act of 2015 (HR 1314) by a vote of 266-167 on October 28th, and the Senate passed the bill on October 30th by a vote of 64-35.

Page 7: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

What the budget deal does: • Suspends the U.S. debt limit until March 15, 2017, after the next presidential

election

• Partially rolls back the sequester and increases discretionary spending caps for FY 2016 and FY 2017

• Caps will increase by $50 billion in FY 2016 and $30 billion in FY 2017, split equally between defense and nondefense spending

Not clear yet how much each appropriations subcommittee will receive for FY16

What the budget deal does not do: • Make appropriations for FY16 – we still have Dec 11 deadline, still risk of

shutdown

• 21 legislative days left

Page 8: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

• Oct. 28 - Rep. Paul Ryan becomes Speaker of the House- pledges “bottom up” effort to unite the House GOP

Page 9: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

• The President signed the bill into law on November 2.

Page 10: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

QtomUOQUOTABLE: “Nobody's going to be popping champagne corks at either end of Pennsylvania Avenue over this bill,” — Rep. Tom Cole, R-Okla. TABLE: “Nobody's going to be popping champagne corks at either end of Pennsylvania Avenue over this bill,” — Rep. Tom Cole, R-Okla.

Compromise Deal

• “I would say it was a good week for those of us who want to govern and a tough week for those who don’t,” said Rep. Charlie Dent, a leader in the GOP centrist Tuesday Group

• Rep. Tom Cole “No one’s popping champagne corks on either end of Pennsylvania Avenue”

Page 11: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

11

Appropriations: What to Expect Next

Continuing Resolution #1 – expires December 11th

Highway Funding bill – expires November 25th

Omnibus for FY16

Issue will be policy riders

Speaker Ryan at odds with Dems and WH already

Stay tuned...

Page 12: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

QUESTIONS?

Page 13: NCI Legislative Update...NCI Legislative Update Clinical Trials and Translational Research Advisory Committee November 4, 2015 M.K. Holohan, J.D. Director NCI Office of Government

www.cancer.gov www.cancer.gov/espanol